• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管抗凝血酶水平正常,但发现携带SERPINC1 rs2227589基因多态性的患者出现多处脑静脉窦血栓形成:一例报告。

Patients with SERPINC1 rs2227589 polymorphism found to have multiple cerebral venous sinus thromboses despite a normal antithrombin level: A case report.

作者信息

Liao Feng, Zeng Jun-Ling, Pan Jian-Gang, Ma Jing, Zhang Zhi-Jian, Lin Zhi-Jun, Lin Li-Feng, Chen Yu-Sen, Ma Xiao-Tang

机构信息

Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong Province, China.

出版信息

World J Clin Cases. 2022 Jan 14;10(2):618-624. doi: 10.12998/wjcc.v10.i2.618.

DOI:10.12998/wjcc.v10.i2.618
PMID:35097087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8771368/
Abstract

BACKGROUND

The hereditary antithrombin (AT) deficiency caused by SERPINC1 gene mutation is an autosomal dominant thrombotic disorder. An increasing number of studies have shown that mutations in the SERPINC1 rs2227589 polymorphic site are correlated with a risk of venous thromboembolism (VTE) at common sites, such as lower extremity deep venous thrombosis and pulmonary thromboembolism. Currently, there are no reports of cerebral venous sinus thrombosis (CVST), a VTE site with a low incidence rate and rs2227589 polymorphism.

CASE SUMMARY

Here, we report a Chinese CVST case with a mutation of the SERPINC1 rs2227589 polymorphic site, which did not cause significant AT deficiency. In a 50-year-old male patient presenting with multiple cerebral venous sinus thromboses no predisposing factors were detected, although a relative had a history of lower extremity deep venous thrombosis. We performed sequencing of the SERPINC1 gene for the patient and his daughter, which revealed the same heterozygous mutation at the rs2227589 polymorphic site: c.41+141G>A.

CONCLUSION

The results showed that more studies should be conducted to assess the correlation between rs2227589 polymorphism and CVST.

摘要

背景

由SERPINC1基因突变引起的遗传性抗凝血酶(AT)缺乏症是一种常染色体显性遗传性血栓形成性疾病。越来越多的研究表明,SERPINC1基因rs2227589多态性位点的突变与常见部位静脉血栓栓塞(VTE)的风险相关,如下肢深静脉血栓形成和肺血栓栓塞。目前,尚无关于脑静脉窦血栓形成(CVST)这一发病率较低的VTE部位与rs2227589多态性的报道。

病例摘要

在此,我们报告1例中国CVST病例,其SERPINC1基因rs2227589多态性位点发生突变,但未导致明显的AT缺乏。在1例50岁男性患者中,尽管其亲属有下肢深静脉血栓形成病史,但未检测到其患有多处脑静脉窦血栓形成的诱发因素。我们对该患者及其女儿进行了SERPINC1基因测序,结果显示rs2227589多态性位点存在相同的杂合突变:c.41+141G>A。

结论

结果表明,应开展更多研究以评估rs2227589多态性与CVST之间的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/4f96fbd5dfc0/WJCC-10-618-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/ed8d2d421f3c/WJCC-10-618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/7dd2e7ef2a30/WJCC-10-618-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/4f96fbd5dfc0/WJCC-10-618-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/ed8d2d421f3c/WJCC-10-618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/7dd2e7ef2a30/WJCC-10-618-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b966/8771368/4f96fbd5dfc0/WJCC-10-618-g003.jpg

相似文献

1
Patients with SERPINC1 rs2227589 polymorphism found to have multiple cerebral venous sinus thromboses despite a normal antithrombin level: A case report.尽管抗凝血酶水平正常,但发现携带SERPINC1 rs2227589基因多态性的患者出现多处脑静脉窦血栓形成:一例报告。
World J Clin Cases. 2022 Jan 14;10(2):618-624. doi: 10.12998/wjcc.v10.i2.618.
2
Association of Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population.中国人群中基因多态性(rs2227589)与肺栓塞风险的关联
Front Genet. 2019 Sep 13;10:844. doi: 10.3389/fgene.2019.00844. eCollection 2019.
3
Missense mutation of (p.Ser426Leu) in a young patient presenting as refractory and recurrent venous thromboembolism: A case report.一名表现为难治性复发性静脉血栓栓塞的年轻患者中 (p.Ser426Leu) 的错义突变:病例报告
Front Cardiovasc Med. 2022 Aug 24;9:903785. doi: 10.3389/fcvm.2022.903785. eCollection 2022.
4
A novel mutation of SERPINC1 in a patient presenting as recurrent cerebral sinus venous and portal vein thrombosis.一名表现为复发性脑静脉窦和门静脉血栓形成的患者中SERPINC1的新型突变。
Blood Coagul Fibrinolysis. 2020 Apr;31(3):229-232. doi: 10.1097/MBC.0000000000000893.
5
Multiple venous thromboembolisms in a pregnant patient carrying a novel mutation in SERPINC1 (p.M313T) that causes a transient antithrombin deficiency: a case report.一名携带SERPINC1基因新突变(p.M313T)导致短暂抗凝血酶缺乏的孕妇发生多次静脉血栓栓塞:病例报告
Thromb J. 2023 Dec 13;21(1):123. doi: 10.1186/s12959-023-00571-7.
6
Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report.由抗凝血酶 III 基因突变位点 SERPINC1 引起的非典型性肺血栓栓塞症:一例报告。
Medicine (Baltimore). 2024 Aug 2;103(31):e39175. doi: 10.1097/MD.0000000000039175.
7
Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.新型丝氨酸蛋白酶抑制剂 C1(SERPINC1)错义突变(Cys462Tyr)导致 279Cys-462Cys 二硫键断裂,引起Ⅰ型遗传性抗凝血酶缺乏症。
Clin Biochem. 2020 Nov;85:38-42. doi: 10.1016/j.clinbiochem.2020.07.004. Epub 2020 Aug 1.
8
Pulmonary thromboembolism associated with hereditary antithrombin III deficiency: A case report.遗传性抗凝血酶 III 缺乏症相关肺血栓栓塞症:一例报告。
Medicine (Baltimore). 2024 Mar 8;103(10):e37429. doi: 10.1097/MD.0000000000037429.
9
Favourable outcome of multisystem venous thrombosis associated with novel SERPINC1 mutation after treated with dabigatran: a case report with 7-year follow-up.达比加群治疗后与新型SERPINC1突变相关的多系统静脉血栓形成的良好结局:一项7年随访的病例报告
Thromb J. 2022 Dec 28;20(1):81. doi: 10.1186/s12959-022-00446-3.
10
New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.SERPINC1 基因新的遗传变异:遗传性抗凝血酶缺陷症病例报告、家族性血栓形成及遗传咨询的考虑。
BMC Med Genet. 2020 Apr 6;21(1):73. doi: 10.1186/s12881-020-01001-5.

本文引用的文献

1
Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions.脑静脉和内脏静脉血栓形成:进展、挑战与未解之谜
J Clin Med. 2020 Mar 10;9(3):743. doi: 10.3390/jcm9030743.
2
Association of Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population.中国人群中基因多态性(rs2227589)与肺栓塞风险的关联
Front Genet. 2019 Sep 13;10:844. doi: 10.3389/fgene.2019.00844. eCollection 2019.
3
ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy.美国妇产科医师学会实践公告第 197 号:妊娠期遗传性血栓形成倾向。
Obstet Gynecol. 2018 Jul;132(1):e18-e34. doi: 10.1097/AOG.0000000000002703.
4
European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology.欧洲卒中组织脑静脉血栓形成诊断与治疗指南- 欧洲神经病学学会认可。
Eur J Neurol. 2017 Oct;24(10):1203-1213. doi: 10.1111/ene.13381. Epub 2017 Aug 20.
5
Oral Contraceptives and HRT Risk of Thrombosis.口服避孕药与激素替代疗法的血栓形成风险
Clin Appl Thromb Hemost. 2018 Mar;24(2):217-225. doi: 10.1177/1076029616683802. Epub 2017 Jan 4.
6
Thrombophilia Screening: Universal, Selected, or Neither?血栓形成倾向筛查:普遍筛查、选择性筛查还是两者皆不?
Clin Appl Thromb Hemost. 2017 Nov;23(8):893-899. doi: 10.1177/1076029616683803. Epub 2017 Jan 4.
7
Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.日本患者抗凝血酶缺乏症的致病基因突变及其临床背景
Int J Hematol. 2017 Mar;105(3):287-294. doi: 10.1007/s12185-016-2142-8. Epub 2016 Nov 17.
8
Causes of venous thrombosis.静脉血栓形成的原因。
Thromb J. 2016 Oct 4;14(Suppl 1):24. doi: 10.1186/s12959-016-0108-y. eCollection 2016.
9
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.遗传性和获得性血栓形成倾向的评估与治疗指南。
J Thromb Thrombolysis. 2016 Jan;41(1):154-64. doi: 10.1007/s11239-015-1316-1.
10
Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.印度深静脉血栓形成患者的抗凝血酶III缺乏症:鉴定首个基于印度的抗凝血酶变体,包括导致聚集的新型点突变(T280A)
PLoS One. 2015 Mar 26;10(3):e0121889. doi: 10.1371/journal.pone.0121889. eCollection 2015.